Date: Thu, 18 Dec 1997 20:08:28 GMT
Server: Apache/1.1.3
Content-type: text/html
Content-length: 6215
Last-modified: Mon, 10 Nov 1997 17:40:22 GMT
Non-Invasive Monitoring Systems, Inc.
Non-Invasive Monitoring Systems, Inc.
(Nims)
Current Business Directions
Nims is Prepared:
-
To
license its current technologies on a non-exclusive basis for manufacture
and distribution.
-
To
design products, incorporating its technologies, based upon specifications
requested by other companies; licenses can either be non-exclusive or exclusive.
-
To
develop products for incorporation into new infant apnea monitors and adult
monitors in the home which are based upon pending patent applications;
these products can be licensed for manufacture and distribution on a non-exclusive
or exclusive basis.
-
To
develop its non-invasive monitors of cardiac function (TCG) and central
venous pressure into a commercially acceptable product upon request from
another company who will manufacture and distribute these products.
-
To
submit for FDA 510(k) approval its already developed software package for
time series analysis of heart rate variability and respiratory sinus arrhythmia
upon request from another company who will market this product.
-
To
develop software for self-titrating CPAP based upon Respitrace and RespiEvents
upon request from another company who will market this product.
-
To
develop a high frequency respiratory monitor suitable for monitoring patients
on high frequency ventilators - as with all Nims' respiratory monitors,
this would measure volume of air delivered to the lungs, not at the airway.
Research &
Development Contractual Arrangements or Licenser Inquiries:
Lee
Rickles, COO
Nims, Inc.
1840 West Avenue, Miami Beach, FL 33139 USA
Tel. 305-534-3694 Fax 305 534-9368
E-Mail nims@ctech.net
All contents Copyright 1997 Nims, Inc. All rights
reserved.
Respitrace,
Respitrace Plus, Respiband are registered trademarks of Nims, Inc.